Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Veerman

Showing results (91-100 of 153) with videos related to

Pageof 16
Sort By:
Cancer|December 15, 1987
Bone marrow magnetic resonance studies in childhood leukemia. Evaluation of osteonecrosisR Pieters, A I van Brenk, A J Veerman, et al.
Annals of Hematology|May 29, 1999
Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemiaA E Duyn, G J Kaspers, R Pieters, et al.
Leukemia|March 1, 1993
Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemiaR Pieters, G J Kaspers, E R van Wering, et al.
European Journal of Haematology|September 1, 1989
Osteonecrosis following chemotherapy for leukemiaR Pieters, A M van der Schans-Dop, A I van Brenk, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistanceE G Haarman, G J Kaspers, R Pieters, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1985
Handmirror cells in childhood acute lymphoblastic leukemia related to immunological phenotypeP H Hogeman, A J Veerman, F C de Waal, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemiaR Pieters, G J Kaspers, E R van Wering, et al.
British Journal of Haematology|June 1, 1996
In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemiaE Klumper, G J Ossenkoppele, R Pieters, et al.
Medical and Pediatric Oncology|July 6, 2000
Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study GroupL A Rammeloo, A Postma, M A Sobotka-Plojhar, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 2, 1994
[Clinical relevance of resistance against cytostatic agents in children with leukemia]R Pieters, G J Kaspers, E Klumper, et al.
Pageof 16

Showing results (91-100 of 153) with videos related to

Sort By:
Pageof 16
Cancer|December 15, 1987
Bone marrow magnetic resonance studies in childhood leukemia. Evaluation of osteonecrosisR Pieters, A I van Brenk, A J Veerman, et al.
Annals of Hematology|May 29, 1999
Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemiaA E Duyn, G J Kaspers, R Pieters, et al.
Leukemia|March 1, 1993
Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemiaR Pieters, G J Kaspers, E R van Wering, et al.
European Journal of Haematology|September 1, 1989
Osteonecrosis following chemotherapy for leukemiaR Pieters, A M van der Schans-Dop, A I van Brenk, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistanceE G Haarman, G J Kaspers, R Pieters, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1985
Handmirror cells in childhood acute lymphoblastic leukemia related to immunological phenotypeP H Hogeman, A J Veerman, F C de Waal, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemiaR Pieters, G J Kaspers, E R van Wering, et al.
British Journal of Haematology|June 1, 1996
In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemiaE Klumper, G J Ossenkoppele, R Pieters, et al.
Medical and Pediatric Oncology|July 6, 2000
Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study GroupL A Rammeloo, A Postma, M A Sobotka-Plojhar, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 2, 1994
[Clinical relevance of resistance against cytostatic agents in children with leukemia]R Pieters, G J Kaspers, E Klumper, et al.
Pageof 16